Search details
1.
Coinhibitory Pathways in Immunotherapy for Cancer.
Annu Rev Immunol
; 34: 539-73, 2016 05 20.
Article
in English
| MEDLINE | ID: mdl-26927206
2.
GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation.
Immunity
; 50(4): 796-811, 2019 04 16.
Article
in English
| MEDLINE | ID: mdl-30995500
3.
A vaccine targeting resistant tumours by dual T cell plus NK cell attack.
Nature
; 606(7916): 992-998, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35614223
4.
Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model.
Cell
; 148(4): 739-51, 2012 Feb 17.
Article
in English
| MEDLINE | ID: mdl-22341446
5.
Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing.
PLoS Biol
; 20(1): e3001532, 2022 01.
Article
in English
| MEDLINE | ID: mdl-35085231
6.
Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.
Cancer Immunol Immunother
; 71(12): 2943-2955, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35523889
7.
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II-III and metastatic breast cancers.
Breast Cancer Res Treat
; 194(1): 65-78, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35482127
8.
In vivo discovery of immunotherapy targets in the tumour microenvironment.
Nature
; 506(7486): 52-7, 2014 Feb 06.
Article
in English
| MEDLINE | ID: mdl-24476824
9.
Identification and characterization of an alternative cancer-derived PD-L1 splice variant.
Cancer Immunol Immunother
; 68(3): 407-420, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30564890
10.
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.
Cytotherapy
; 20(7): 952-963, 2018 07.
Article
in English
| MEDLINE | ID: mdl-30180944
11.
Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response.
J Neurooncol
; 137(2): 269-278, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29322427
12.
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated Mice.
J Immunol
; 197(12): 4674-4685, 2016 12 15.
Article
in English
| MEDLINE | ID: mdl-27849169
13.
Cancer immunotherapy comes of age.
Nature
; 480(7378): 480-9, 2011 Dec 21.
Article
in English
| MEDLINE | ID: mdl-22193102
14.
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Gut
; 65(12): 1973-1980, 2016 12.
Article
in English
| MEDLINE | ID: mdl-26311717
15.
High-throughput oncogene mutation profiling in human cancer.
Nat Genet
; 39(3): 347-51, 2007 Mar.
Article
in English
| MEDLINE | ID: mdl-17293865
16.
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy.
Immunol Cell Biol
; 92(6): 475-80, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24732076
17.
Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function.
Blood
; 119(15): e131-8, 2012 Apr 12.
Article
in English
| MEDLINE | ID: mdl-22289890
18.
The Cloning of GM-CSF.
J Immunol
; 198(7): 2519-2521, 2017 04 01.
Article
in English
| MEDLINE | ID: mdl-28320911
19.
Ex vivo characterization and isolation of rare memory B cells with antigen tetramers.
Blood
; 118(2): 348-57, 2011 Jul 14.
Article
in English
| MEDLINE | ID: mdl-21551230
20.
Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade.
Cancer Immunol Res
; 11(8): 1100-1113, 2023 08 03.
Article
in English
| MEDLINE | ID: mdl-37262321